Skip to content
★ Sign in to follow
Syra Health Corp logo

Syra Health Corp Stock: price and insider trades · United States

US·Mcap US$11.8MHealth Care

No insider purchase over the last 90 days. The latest, by Prasad Priya, was filed 13 Sept 2024.

Syra Health Corp: what insiders have been doing

This page follows insider dealings at Syra Health Corp as filed with SEC (Form 4), a company from the Health Care sector. Between 23 October 2025 and 23 October 2026, 1 insider published 2 filings.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

With 2 filings in twelve months, the company is quieter than the median of 8 filings across the 278 companies we follow on the same exchange. Over the whole record (from 2023), the tally stands at 27 purchases and 4 sales. The 10-K for the year ended 31 December 2025 shows 7.2 m USD of revenue and -896,333 USD of net income.

There has been no open-market purchase by an insider of Syra Health Corp for at least a year.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Insider Decl.
33
Thresholds
n/a
Buy Volume
€19,586
27 ops. · all time
Sell Volume
€9,450
4 ops. · all time

Since the insiders bought

  • Filed 13 Sept 2024 · 786 days ago · €1,819
    -81.7%
    Entry US$0.42 · Close at T+365 US$0.08
  • Filed 26 Dec 2023 · 1048 days ago · €230
    -63.8%
    Entry US$1.07 · Close at T+365 US$0.39
  • Filed 26 Dec 2023 · 1049 days ago · €458
    -63.8%
    Entry US$1.07 · Close at T+365 US$0.39

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 19,178 of 26,911 companies
37.2
score / 100
Value
22
Quality
53
FCF yld-3.9%
Earn yld-7.9%
EV/EBITDA·
ROE27%
Gross mgn34%
Net mgn-12%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$0.83
Analyst consensus
·
Income statement
RevenueUS$7.2M
Gross profitUS$2.5M34% margin
EBITDA-US$862.6k-12% margin
Net income-US$896.3k1.6% margin
Valuation
PER (trailing)82.5x
P/Book5.5x
Beta3.37
Balance sheet & cash
Market capUS$11.8M
Total debtUS$143.8k
Free Cash Flow-US$447.9k
Debt / Equity6%
Profitability & ownership
ROE5.2%
ROA1.3%
% insiders51.9%
% institutions0.0%
Last declaration on 28 September 2026
Declarations33 total
  • ◆
    CEOExecutives
    0SEC
    110,537 shares0Restricted Stock UnitsSEC:0001493152-26-044576:0
  • ◆
    CEOExecutives
    0SEC
    110,537 shares0Restricted Stock UnitsSEC:0001493152-26-004918:0
  • ▲
    CFO and COOExecutives
    12 USD0SEC
    10 shares@ US$1.210.1% of flowClass A Common StockSEC:0001493152-24-036127:7
    Canonical exit: 4 Mar 2024 (T+90)
  • ▲
    CFO and COOExecutives
    0SEC
    2,400 sharesClass A Common StockSEC:0001493152-24-036127:1
    Canonical exit: 1 Jan 2024 (T+90)
  • ▼
    CFO and COOExecutives
    3,750 USD27SEC
    500 shares@ US$7.5016.0% of flowClass A Common StockSEC:0001493152-24-036127:13
  • ▲
    CFO and COOExecutives
    2,015 USD26SEC
    5,303 shares@ US$0.388.4% of flowClass A Common StockSEC:0001493152-24-036127:14
    Canonical exit: 11 Dec 2024 (T+90)
  • ▼
    CFO and COOExecutives
    2,928 USD22SEC
    918 shares@ US$3.1912.8% of flowClass A Common StockSEC:0001493152-24-036127:2
  • ▲
    CFO and COOExecutives
    2,660 USD22SEC
    1,000 shares@ US$2.6611.6% of flowClass A Common StockSEC:0001493152-24-036127:3
    Canonical exit: 7 Jan 2024 (T+90)
  • ▲
    CFO and COOExecutives
    535 USD41SEC
    435 shares@ US$1.232.3% of flowClass A Common StockSEC:0001493152-24-036127:4
    Canonical exit: 29 Feb 2024 (T+90)
  • ▲
    CFO and COOExecutives
    4,869 USD45SEC
    4,271 shares@ US$1.1420.6% of flowClass A Common StockSEC:0001493152-24-036127:5
    Canonical exit: 3 Mar 2024 (T+90)
  • ▼
    CFO and COOExecutives
    845 USD25SEC
    735 shares@ US$1.153.6% of flowClass A Common StockSEC:0001493152-24-036127:6
  • ▼
    CFO and COOExecutives
    2,620 USD26SEC
    2,000 shares@ US$1.3111.1% of flowClass A Common StockSEC:0001493152-24-036127:8
  • ▲
    CFO and COOExecutives
    61 USD43SEC
    50 shares@ US$1.220.3% of flowClass A Common StockSEC:0001493152-24-036127:9
    Canonical exit: 5 Mar 2024 (T+90)
  • ▲
    CFO and COOExecutives
    12 USD43SEC
    10 shares@ US$1.220.1% of flowClass A Common StockSEC:0001493152-24-036127:10
    Canonical exit: 6 Mar 2024 (T+90)
  • ▲
    CFO and COOExecutives
    62 USD43SEC
    50 shares@ US$1.230.3% of flowClass A Common StockSEC:0001493152-24-036127:11
    Canonical exit: 7 Mar 2024 (T+90)
  • ▲
    CFO and COOExecutives
    1 USD43SEC
    1 shares@ US$1.180.0% of flowClass A Common StockSEC:0001493152-24-036127:12
    Canonical exit: 20 Mar 2024 (T+90)
  • ▲
    CFO and COOExecutives
    3,029 USD27SEC
    918 shares@ US$3.30100.0% of flowClass A Common StockSEC:0001493152-24-036127:0
    Canonical exit: 28 Dec 2023 (T+90)
  • ▲
    10% OwnerExecutives
    251 USD23SEC
    220 shares@ US$1.1410.4% of flowClass A Common StockSEC:0001493152-23-046136:1
    Canonical exit: 3 Mar 2024 (T+90)
  • ▲
    10% OwnerExecutives
    429 USD26SEC
    320 shares@ US$1.3417.9% of flowClass A Common StockSEC:0001493152-23-046136:2
    Canonical exit: 4 Mar 2024 (T+90)
  • ▲
    10% OwnerExecutives
    266 USD27SEC
    200 shares@ US$1.3311.2% of flowClass A Common StockSEC:0001493152-23-046136:3
    Canonical exit: 5 Mar 2024 (T+90)
  • ▲
    10% OwnerExecutives
    272 USD27SEC
    200 shares@ US$1.3611.4% of flowClass A Common StockSEC:0001493152-23-046136:4
    Canonical exit: 12 Mar 2024 (T+90)
  • ▲
    10% OwnerExecutives
    249 USD27SEC
    175 shares@ US$1.4210.3% of flowClass A Common StockSEC:0001493152-23-046136:5
    Canonical exit: 13 Mar 2024 (T+90)
  • ▲
    CEOExecutives
    498 USD45SEC
    426 shares@ US$1.17100.0% of flowClass A Common StockSEC:0001493152-23-046135:0
    Canonical exit: 3 Mar 2024 (T+90)
  • ▲
    Executives
    937 USD25SEC
    710 shares@ US$1.32100.0% of flowClass A Common StockSEC:0001493152-23-046136:0
    Canonical exit: 26 Feb 2024 (T+90)
  • ▲
    President and ChairExecutives
    73 USD37SEC
    60 shares@ US$1.221.4% of flowClass A Common StockSEC:0001493152-23-046134:0
    Canonical exit: 26 Feb 2024 (T+90)

25 of 33 declarations

About Syra Health Corp

Syra Health Corp is a company listed on the XNAS market, specializing in the healthcare sector. It focuses on developing innovative solutions to enhance healthcare services.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations